ESCI期刊Current Reviews in Clinical and Experimental Pharmacology 2024/2025影响因子:1.329 (CURR REV CLIN EXP PH) (2772-4328).

显示全部楼层 · 发表于 2025-3-26 21:09:34

Submitted on: 06 February 2003. Revised on: 03 May 2003. Accepted on: 22 May 2003. ___________________Current Reviews in Clinical and Experimental Pharmacology

显示全部楼层 · 发表于 2025-3-27 04:30:11

Submitted on: 10 September 1998. Revised on: 28 December 1998. Accepted on: 07 February 1999. ___________________Current Reviews in Clinical and Experimental Pharmacology

显示全部楼层 · 发表于 2025-3-27 05:24:29

Submitted on: 31 May 2008. Revised on: 01 July 2008. Accepted on: 24 August 2008. ___________________Current Reviews in Clinical and Experimental Pharmacology

显示全部楼层 · 发表于 2025-3-27 13:22:50

显示全部楼层 · 发表于 2025-3-27 14:08:55

Submitted on: 14 May 2016. Revised on: 04 June 2016. Accepted on: 18 June 2016. ___________________Current Reviews in Clinical and Experimental Pharmacology

显示全部楼层 · 发表于 2025-3-27 18:31:31

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-3 17:14
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

ESCI期刊Current Reviews in Clinical and Experimental Pharmacology 2024/2025影响因子:1.329 (CURR REV CLIN EXP PH) (2772-4328).

浏览过的版块